Page last updated: 2024-09-03

carglumic acid and Orphan Diseases

carglumic acid has been researched along with Orphan Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ah Mew, N; Shi, D; Tuchman, M; Zhao, G	1
Leonard, JV; Richmond, S	1

Other Studies

2 other study(ies) available for carglumic acid and Orphan Diseases

Article	Year
Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes. Molecular genetics and metabolism, 2017, Volume: 120, Issue:3 Topics: Adenosine Triphosphate; Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Drug Therapy, Combination; Female; Glutamates; Humans; Male; Mice; Mutation; Precision Medicine; Protein Stability; Protein Structure, Tertiary; Rare Diseases	2017
Pricing of orphan drugs. Lancet (London, England), 2009, Feb-07, Volume: 373, Issue:9662 Topics: Economics, Pharmaceutical; Glutamates; Humans; Orphan Drug Production; Rare Diseases; Therapeutic Equivalency	2009

Article

Year

Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes.

Molecular genetics and metabolism, 2017, Volume: 120, Issue:3

Topics: Adenosine Triphosphate; Animals; Carbamoyl-Phosphate Synthase (Ammonia); Carbamoyl-Phosphate Synthase I Deficiency Disease; Drug Therapy, Combination; Female; Glutamates; Humans; Male; Mice; Mutation; Precision Medicine; Protein Stability; Protein Structure, Tertiary; Rare Diseases

2017

Pricing of orphan drugs.

Lancet (London, England), 2009, Feb-07, Volume: 373, Issue:9662

Topics: Economics, Pharmaceutical; Glutamates; Humans; Orphan Drug Production; Rare Diseases; Therapeutic Equivalency

2009